As of today, products containing natural cannabidiol (CBD) intended for oral use are classed in Italy as narcotic drugs.
Following a decree issued on 7 August 2023 – entering into force on 20 September and adding CBD to Italy’s list of narcotic and psychotropic substances – such products can only be
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on HBW Insight for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?